[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-CSN-131026158--":3,"related-articles-undefined-undefined-3b0c143a-1ddd-4edc-8eae-c9192ac88aac-true":15},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"orgId":13,"description":14},"CSN-131026158","PRESSRELEASE"," Suvoda makes Sofia AI assistant available for clinical trials to drive faster answers and action","2026-10-13T17:01:25.000+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Fimg\u002Fpr-newswire.png","Economie","PR Newswire",true,"\u003Cp> Key Takeaways\u003C\u002Fp>\u003Cp> - Clinical trials require guard railed AI that's purpose built for the regulated industry that has high human stakes and required audit trails.\u003C\u002Fp>\u003Cp> - Sofia helps make complex, fast-moving trial data more accessible to study teams who manage large volumes of time-sensitive work.\u003C\u002Fp>\u003Cp> - Study teams can get faster answers and take confident action. Sofia goes beyond information retrieval and can execute authorized system actions on behalf of busy users while maintaining the permissions and audit trails required in clinical trials.\u003C\u002Fp>\u003Cp> CONSHOHOCKEN, Pa., Oct. 13, 2026 \u002FPRNewswire\u002F -- Suvoda, a global clinical trial technology company, today announced that Sofia, its AI \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fedge.prnewswire.com\u002Fc\u002Flink\u002F?t=0&l=en&o=4793780-1&h=3295406313&u=https%3A%2F%2Fwww.suvoda.com%2Fai-assistant-for-clinical-trials&a=Sofia%2C+its+AI+assistant\">assistant\u003C\u002Fa> on the Suvoda Platform, is ready for all new clinical trials using Suvoda RTSM\u002FIRT or Suvoda eCOA. Sofia gives sponsors, CROs, and sites faster access to trial data and the ability to act on it—through AI built for regulated clinical research.\u003C\u002Fp>\u003Cp> \"Sofia handles the routine operational work so that sponsors, CROs, and sites can focus on the decisions that require their judgment,\" said E.K. Koh, Chief Product Officer, Suvoda. \"We built it with the rigor clinical trials demand because in this environment there is no room for a wrong answer.\"\u003C\u002Fp>\u003Cp> Clinical trial teams manage high volumes of time-sensitive work. They track drug inventory, review shipment details, monitor patient visit schedules, and manage questionnaire compliance across global sites. Checking those data streams can pull attention away from patients and judgment-intensive decisions. Sofia is designed to change that equation. The goal is to make complex, fast-moving trial data more accessible so teams can focus their attention where human expertise matters most.\u003C\u002Fp>\u003Cp> Sofia launched first with early adopter companies that helped shape it before today's expansion to all new Suvoda RTSM\u002FIRT and eCOA trials.\u003C\u002Fp>\u003Cp> \"As an early adopter, we were impressed by how quickly our teams incorporated Sofia into their daily workflow,\" said Dawn Sorenson, Director, IRT Center of Excellence, Daiichi Sankyo. \"The platform's ability to summarize documentation and answer operational questions makes information more accessible and reduces the time spent navigating systems or pulling reports. Tasks that once required multiple steps can now be addressed through a simple conversation, creating meaningful efficiency gains across study operations.\"\u003C\u002Fp>\u003Cp> Built differently than general-purpose AI\u003C\u002Fp>\u003Cp> Some AI tools apply a large language model to a problem and hope the output is accurate. Sofia is built differently. Conversational AI maps each question's intent to Suvoda's validated knowledge space, where subject matter experts have translated expert guidance into validated skills. Those skills execute against live study data within a governed framework that protects the study blind and creates the audit trail clinical trials require. Today, Sofia supports more than 40 topics and is expanding continuously.\u003C\u002Fp>\u003Cp> From information to action\u003C\u002Fp>\u003Cp> Sofia does not stop with just answering questions. For authorized users, Sofia can execute system actions on their behalf in a single conversation. Before acting, Sofia summarizes what it will do and asks for confirmation. Every action is attributed to the requesting user, governed by existing roles and permissions, and captured in a full audit trail.\u003C\u002Fp>\u003Cp> Sofia recently received the PM360 Innovation \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fedge.prnewswire.com\u002Fc\u002Flink\u002F?t=0&l=en&o=4793780-1&h=2602202828&u=https%3A%2F%2Fwww.suvoda.com%2Finsights%2Fall-news%2Fsuvoda-earns-two-pm360-innovation-awards-for-sofia-ai-assistant-and-suvoda-app&a=PM360+Innovation+Award\">Award\u003C\u002Fa> in the Artificial Intelligence category, reflecting the pragmatic yet innovative approach Suvoda took to create Sofia. Early adopters were instrumental to creating a system that really works for what study teams need.\u003C\u002Fp>\u003Cp> Frequently Asked Questions\u003C\u002Fp>\u003Cp> Q: How does Sofia handle data privacy and security? A: Sofia operates with a zero-data retention policy, never uses customer data to train public models, and scopes every user's access to exactly what they are already authorized to see within the Suvoda Platform.\u003C\u002Fp>\u003Cp> Q: How is Sofia different from a general chatbot? A: Sofia is a purpose-built, deterministic AI assistant that executes Suvoda-authored expert instructions against live clinical trial data within a governed framework, and it can also take authorized system actions on a user's behalf after obtaining confirmation from the user.\u003C\u002Fp>\u003Cp> Q: What languages does Sofia support? A: Sofia responds in the language of the question, supporting global sponsor, CRO, and site teams operating across time zones and regions.\u003C\u002Fp>\u003Cp> Media Contact:\u003C\u002Fp>\u003Cp> Robin Abadía\u003C\u002Fp>\u003Cp> Director, External Communications, Suvoda\u003C\u002Fp>\u003Cp> \u003Ca target=\"_blank\" href=\"mailto:marketing@suvoda.com\">marketing@suvoda.com\u003C\u002Fa>\u003C\u002Fp>\u003Cp> For more Suvoda news, visit our \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fedge.prnewswire.com\u002Fc\u002Flink\u002F?t=0&l=en&o=4793780-1&h=3391258579&u=https%3A%2F%2Fwww.suvoda.com%2Finsights%2Fall%3Fcategory%3Dnews%26p%3D1&a=our+newsroom\">newsroom.\u003C\u002Fa>\u003C\u002Fp>\u003Cp> View original content to download multimedia:https:\u002F\u002Fwww.prnewswire.co.uk\u002Fnews-releases\u002Fsuvoda-makes-sofia-ai-assistant-available-for-clinical-trials-to-drive-faster-answers-and-action-302903885.html\u003C\u002Fp>","3b0c143a-1ddd-4edc-8eae-c9192ac88aac","Key Takeaways - Clinical trials require guard railed AI that's purpose built for the regulated industry that has high human stakes and required audit trails. - ",[16,21,26,27,32,37,42,47,52,57],{"id":17,"title":18,"pubDate":19,"logoUrl":8,"thirdParty":11,"orgId":13,"description":20},"CSN-131026177"," EICMA 2026: ALWAYS LIKE THE FIRST TIME, BUT NEVER THIS BIG","2026-10-13T18:37:25.000+02:00","The 83rd edition becomes the largest ever held at Fiera Milano Rho: ten exhibition halls, over 300,000 square metres, 754 exhibitors and 2,120 brands from 52 co",{"id":22,"title":23,"pubDate":24,"logoUrl":8,"thirdParty":11,"orgId":13,"description":25},"CSN-131026163"," Stelios nam het met easyJet op tegen de luchtvaartmaatschappijen. Nu neemt hij het op tegen de onlinewinkelgiganten","2026-10-13T17:27:25.000+02:00","- easyShop.com lanceert in 21 Europese landen als uitdager van Amazon - De marktplaats houdt geen voorraad aan, verkoopt geen huismerkproducten en concurreert n",{"id":4,"title":6,"pubDate":7,"logoUrl":8,"thirdParty":11,"orgId":13,"description":14},{"id":28,"title":29,"pubDate":30,"logoUrl":8,"thirdParty":11,"orgId":13,"description":31},"CSN-131026154"," SmartSens Showcases Automotive Vision Sensing Portfolio at AutoSens Europe 2026","2026-10-13T16:51:24.000+02:00","SmartSens presents automotive-grade image sensors and integrated imaging-and-computing solutions for a range of vehicle applications BARCELONA, Spain, Oct. 13, ",{"id":33,"title":34,"pubDate":35,"logoUrl":8,"thirdParty":11,"orgId":13,"description":36},"CSN-131026143"," Building on Abacum Intelligence, Abacum Launches Modeler and Brings Agentic Modeling to Every Finance Team","2026-10-13T16:08:25.000+02:00","The AI-native FP&A platform brings expert-grade modeling to every finance team. Describe the plan in natural language, and Modeler builds it on live company dat",{"id":38,"title":39,"pubDate":40,"logoUrl":8,"thirdParty":11,"orgId":13,"description":41},"CSN-131026137"," HOZO Hobby Knife: A Maker's Workspace That Unfolds Anywhere, Launches on Kickstarter","2026-10-13T15:31:25.000+02:00","Featuring a push-button blade-changing mechanism and an integrated cutting station, HOZO Hobby Knife is designed for makers and hobbyists. HONG KONG, Oct. 13, 2",{"id":43,"title":44,"pubDate":45,"logoUrl":8,"thirdParty":11,"orgId":13,"description":46},"CSN-131026127"," CurTec expands US manufacturing and warehouse capacity in Westminster, S.C.","2026-10-13T15:02:25.000+02:00","Expansion strengthens local production and supply for North American customers WESTMINSTER, S.C., Oct. 13, 2026 \u002FPRNewswire\u002F -- CurTec USA is investing $10 mill",{"id":48,"title":49,"pubDate":50,"logoUrl":8,"thirdParty":11,"orgId":13,"description":51},"CSN-131026109"," IDC Raises 2029 Forecast for OCP-Recognized Infrastructure Spending by 2.7x to $800 Billion","2026-10-13T14:02:25.000+02:00","Annual study commissioned by the Open Compute Project Foundation projects spending will reach $892 billion in 2030 as AI investment and adoption expand SAN JOSE",{"id":53,"title":54,"pubDate":55,"logoUrl":8,"thirdParty":11,"orgId":13,"description":56},"CSN-131026107"," Pudu Robotics' PUDU BG1 Series Wins Two ISSA Awards, Reinforcing Global Leadership in Commercial Cleaning Robotics","2026-10-13T14:01:24.000+02:00","SHENZHEN, China, Oct. 13, 2026 \u002FPRNewswire\u002F -- Pudu Robotics, a global leader in commercial service robotics, has received two awards for its PUDU BG1 Series at",{"id":58,"title":59,"pubDate":60,"logoUrl":8,"thirdParty":11,"orgId":13,"description":61},"CSN-131026096"," IQVIA Selects Veeva Clinical Operations Applications","2026-10-13T13:04:25.000+02:00","RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif., Oct. 13, 2026 \u002FPRNewswire\u002F -- IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion"]